|
|
Article: PharmaVitae 2002: Kirin Brewery.
- Article from:
- M2 Presswire
- Article date:
- February 23, 2003
CopyrightCOPYRIGHT 2003 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-23 February 2003-Research and Markets: PharmaVitae 2002: Kirin Brewery(C)1994-2003 M2 COMMUNICATIONS LTD
RDATE:02202003
This analysis examines the current position and future outlook for Kirin in the ethical pharmaceutical sector. It encompasses company strategy, comparative portfolio and pipeline analysis and assessment of financial performance, providing 1, 3 and 6 year sales forecasts for key drugs.Assess Kirin's dependence on the launch of new drugs such as PB-94 and CliniMACS (CD34+) for short-to mid-term pharmaceutical growth
Evaluate the strength of Kirin's biotechnology alliance networks and the opportunities for future ...